Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of allogeneic mesenchymal stem cell infusions for post–allogeneic transplant cytopenias
2013-000534-35Phase 2Completed
- Sponsor
- Fundación Castellano Leonesa de Hematología y Hemoterapia
- Start
- Apr 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mesenchymal stem cells in cytopenia and Immune disorder, sponsored by Fundación Castellano Leonesa de Hematología y Hemoterapia. Primary endpoint: Safety of the procedure. Started Apr 2013; status: completed.
02
Drugs
mesenchymal stem cells
03
Conditions
cytopeniaImmune disorder
Beyond the preview
Go deeper on 2013-000534-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000534-35.